17:29 EST Immix Biopharma (IMMX) files $750M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX:
- Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
- Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
- Immix Biopharma Announces Positive Phase 2 Trial Results
- Immix Biopharma 19.12M share Spot Secondary priced at $5.10
- Immix Biopharma announces phase 2 NXC-201 results